Alto Neuroscience Inc.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ANRO and other ETFs, options, and stocks.About ANRO
Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of psychiatric drugs. Its pipeline is composed of five clinical-stage assets which initially target depressive disorder and schizophrenia population.
CEOAmit Etkin
CEOAmit Etkin
Employees76
Employees76
HeadquartersMountain View, California
HeadquartersMountain View, California
Founded2019
Founded2019
Employees76
Employees76
ANRO Key Statistics
Market cap417.53M
Market cap417.53M
Price-Earnings ratio-5.84
Price-Earnings ratio-5.84
Dividend yield—
Dividend yield—
Average volume245.29K
Average volume245.29K
High today$13.71
High today$13.71
Low today$12.95
Low today$12.95
Open price$13.43
Open price$13.43
Volume201.81K
Volume201.81K
52 Week high$16.49
52 Week high$16.49
52 Week low$1.60
52 Week low$1.60
Stock Snapshot
With a market cap of 417.53M, Alto Neuroscience Inc.(ANRO) trades at $13.43. The stock has a price-to-earnings ratio of -5.84.
On 2025-12-06, Alto Neuroscience Inc.(ANRO) stock traded between a low of $12.95 and a high of $13.71. Shares are currently priced at $13.43, which is +3.7% above the low and -2.0% below the high.
The Alto Neuroscience Inc.(ANRO)'s current trading volume is 201.81K, compared to an average daily volume of 245.29K.
In the last year, Alto Neuroscience Inc.(ANRO) shares hit a 52-week high of $16.49 and a 52-week low of $1.60.
In the last year, Alto Neuroscience Inc.(ANRO) shares hit a 52-week high of $16.49 and a 52-week low of $1.60.
Analyst ratings
90%
of 10 ratingsBuy
90%
Hold
10%
Sell
0%
People also own
Based on the portfolios of people who own ANRO. This list is generated using Robinhood data, and it’s not a recommendation.